ABT 279
Alternative Names: ABT-279Latest Information Update: 22 Jan 2013
At a glance
- Originator Abbott Laboratories
- Class Antihyperglycaemics; Pyrrolidines; Small molecules
- Mechanism of Action Dipeptidyl peptidase 4 inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Type 2 diabetes mellitus